Antibody Drug Conjugates Market
Antibody Drug Conjugates Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Antibody Drug Conjugates Market Size and Growth
The global Antibody Drug Conjugates market is expected to witness significant growth due to increasing prevalence of cancer worldwide. Market size is projected to reach USD 13.89 billion by 2026. Rapid advancements in technology and rising investments in research and development are driving the market growth.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ F. Hoffman-La Roche
◍ Novartis AG
◍ Takeda Pharmaceutical
◍ Pfizer
◍ Seattle Genetics
◍ Genentech
◍ Immunogen
◍ Progenics Pharmaceuticals
◍ Bayer Healthcare Pharmaceuticals
F. Hoffman-La Roche, Novartis AG, Takeda Pharmaceutical, Pfizer, Seattle Genetics, Genentech, Immunogen, Progenics Pharmaceuticals, and Bayer Healthcare Pharmaceuticals are leading players in the Antibody Drug Conjugates market. They utilize ADC technology to develop targeted cancer therapies, contributing to market growth. Sales revenue figures: Roche- $23 billion, Novartis- $12 billion, Seattle Genetics- $900 million.
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
Adcetris
Kadcyla
Breast Cancer
Lymphoma
Market Growth
Request Sample Report
$ X Billion USD
